NPI: 1962768242 · SAINT AUGUSTINE, FL 32086 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/11/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/11/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,824 | $764K |
| 2019 | 13,905 | $1.33M |
| 2020 | 14,508 | $2.04M |
| 2021 | 12,552 | $1.00M |
| 2022 | 6,802 | $1.36M |
| 2023 | 365 | $94K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,201 | 820 | $2.24M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,146 | 1,035 | $2.08M |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,872 | 699 | $1.03M |
| A4657 | Syringe, with or without needle, each | 1,567 | 910 | $380K |
| J1756 | Injection, iron sucrose, 1 mg | 2,667 | 494 | $264K |
| 85041 | 1,129 | 786 | $128K | |
| 85048 | 1,113 | 772 | $123K | |
| 85045 | 986 | 686 | $112K | |
| 83970 | 519 | 346 | $52K | |
| 83550 | 394 | 275 | $43K | |
| 83540 | 394 | 275 | $43K | |
| 82728 | 371 | 258 | $40K | |
| 82108 | 270 | 185 | $33K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 96 | 58 | $8K |
| 82607 | 93 | 61 | $7K | |
| 82746 | 93 | 61 | $7K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 45 | 24 | $0.00 |